Tracelink, Inc.

Tracelink, Inc. is a privately held company that operates as a digital network platform for intelligent orchestration of the supply chain, primarily serving the life sciences and healthcare industries. Founded in 2009, its mission is to protect patients by ensuring critical medicines reach them safely, securely, and on time. The company's global headquarters is located in Wilmington, Massachusetts, USA.

Tracelink's core offerings include its Orchestration Platform for Universal Solutions (OPUS) and the Multienterprise Information Network Tower (MINT), alongside various track-and-trace solutions. These products and services facilitate serialization, compliance with regulations such as the DSCSA, supply chain visibility, and digital recall management. The company connects a vast network of entities, including pharmaceutical manufacturers, 3PLs, CMOs, wholesale distributors, health systems, and retail pharmacies, enabling real-time information sharing and collaborative supply chain management.

Under the leadership of President and CEO Shabbir Dahod, Tracelink is pioneering agentic supply chain orchestration, leveraging AI agents to enhance supply chain operations. The company received a 2026 Globee® Cybersecurity Award for its OPUS platform and was recognized in Fast Company's 2025 Next Big Things in Tech List. Tracelink was also named a leader in the 2025 IDC MarketScape Worldwide Multi-Enterprise Supply Chain Commerce Network Vendor Assessment, underscoring its market positioning and continuous innovation in digitalizing the global life sciences supply chain.

Latest updates

TraceLink's Cybersecurity Award Highlights Agentic Supply Chain Shift

Event summary

  • TraceLink won a 2026 Globee® Cybersecurity Award for its Orchestration Platform for Universal Solutions (OPUS).
  • OPUS secures TraceLink's Agentic Business Network, linking over 315,000 authenticated organizations.
  • The platform processes approximately 300,000 files daily and maintains 99.98%+ availability.
  • TraceLink's network facilitates hundreds of billions of product transactions annually.

The big picture

TraceLink's recognition underscores the growing importance of cybersecurity in increasingly complex, AI-driven supply chains. The shift towards 'agentic' operations, where AI agents autonomously manage tasks, represents a fundamental change in how supply chains function, demanding a new generation of secure, network-native platforms. This trend is particularly acute in highly regulated industries like life sciences and healthcare, where data breaches or operational disruptions can have severe consequences.

What we're watching

Governance Dynamics
The increasing reliance on AI agents within supply chains will necessitate robust governance frameworks, and TraceLink's ability to maintain control and auditability will be critical for continued adoption.
Regulatory Headwinds
Stringent GxP regulations and evolving data privacy laws could create hurdles for TraceLink's expansion, requiring ongoing investment in compliance and security.
Execution Risk
Scaling the Agentic Business Network while maintaining its security and performance will require significant operational expertise and investment in infrastructure.

Devatis Integrates TraceLink MINT to Enable Agentic Order-to-Cash

Event summary

  • Devatis, a U.S. affiliate of Deva Holding A.Ş., has implemented TraceLink's MINT platform for order-to-cash operations.
  • The move replaces fragmented EDI integrations with a network model connecting wholesalers, 3PLs, and other partners.
  • TraceLink’s Integrate-Once™ model aims to reduce onboarding timelines from months to as little as three days.
  • Devatis plans to leverage the centralized data for AI agent-driven monitoring and automation in areas like price validation and shipment reconciliation.
  • TraceLink's OPUS platform currently links over 300,000 entities and processes hundreds of billions of transactions annually.

The big picture

The adoption of TraceLink MINT by Devatis represents a broader trend toward network-based commerce solutions, particularly within the highly regulated pharmaceutical sector. This shift moves beyond traditional EDI, enabling real-time data exchange and laying the groundwork for AI-driven automation. The move highlights the increasing importance of digital infrastructure in managing complex, global supply chains and the potential for AI to optimize operational efficiency.

What we're watching

Agentic Adoption
The success of Devatis’s agentic AI use cases will hinge on data quality and partner buy-in, potentially revealing broader challenges for adoption across the pharmaceutical supply chain.
Network Effects
TraceLink’s ability to attract and retain trading partners within the MINT network will determine the platform’s long-term value proposition and competitive advantage.
Integration Costs
While onboarding is simplified, the ongoing costs and maintenance of the TraceLink network, both for Devatis and its partners, could impact the ROI of this migration.

TraceLink, Kinaxis Integrate for Real-Time Supply Chain Orchestration

Event summary

  • TraceLink and Kinaxis have expanded their partnership to integrate Kinaxis Maestro concurrent planning with TraceLink’s Agentic Business Network.
  • The joint solution, 'Kinaxis Network Collaboration by TraceLink,' aims to synchronize planning decisions with real-time execution data.
  • The integration utilizes TraceLink’s Integrate-Once™ model and Multienterprise Information Network Tower (MINT) to share data and automate processes.
  • TraceLink’s network includes over 300,000 authenticated supply chain entities.

The big picture

The integration reflects a growing trend towards real-time, data-driven supply chain management, particularly within the highly regulated life sciences sector. By combining Kinaxis’ planning capabilities with TraceLink’s network visibility, the companies are attempting to bridge the persistent gap between strategic planning and operational execution, a critical challenge for organizations managing complex, global supply chains. This move signals a shift towards more automated and responsive supply chain ecosystems, reducing reliance on manual processes and improving resilience against disruptions.

What we're watching

Adoption Rate
The success of this partnership hinges on the willingness of TraceLink’s extensive network to adopt Kinaxis’ Maestro platform, which could be a significant undertaking given existing legacy systems.
Agentic Workforce
TraceLink’s emphasis on ‘agentic’ operations requires careful management of AI integration and potential workforce displacement, demanding a clear strategy for human-AI collaboration.
Competitive Response
Other supply chain orchestration providers will likely accelerate their own integration efforts to counter this partnership, potentially leading to a period of intense competition and innovation.

TraceLink Introduces Agentic Business Networks, Redefining Supply Chain Execution

Event summary

  • TraceLink launched OPUS Agents, no-code AI agents designed to execute tasks across supply chain networks.
  • The company is positioning its platform as an 'Agentic Business Network,' a new operating model for supply chains.
  • TraceLink’s OPUS platform connects over 300,000 organizations and processes hundreds of billions of product transactions annually.
  • TraceLink has initiated an 'OPUS Agents Exclusive Access Program' with select customers to test and refine the new agentic workforce model.

The big picture

TraceLink's move to Agentic Business Networks represents a significant shift away from traditional, fragmented supply chain management systems. The increasing complexity of global supply chains, coupled with talent shortages, is driving demand for automated solutions. By embedding AI agents directly into workflows, TraceLink aims to address these challenges and establish itself as a leader in the next generation of supply chain execution, though the model's scalability and security remain to be proven.

What we're watching

Adoption Rate
The success of TraceLink’s Agentic Business Network hinges on rapid adoption by its customer base, and the Exclusive Access Program’s results will be a key indicator of broader market acceptance.
Governance Risk
The reliance on AI agents within regulated industries like life sciences introduces new governance and compliance risks that TraceLink must proactively address to maintain trust and avoid regulatory scrutiny.
Competitive Response
Other supply chain software providers will likely respond to TraceLink’s agentic approach, potentially leading to a period of intense competition and innovation in the market.

TraceLink Executive's Award Signals AI Orchestration Push in Life Sciences

Event summary

  • Jerry Meyer, VP of OPUS Core Platform Development at TraceLink, received a 2026 'Pros to Know' award from Supply & Demand Chain Executive.
  • The award recognizes Meyer's leadership in advancing agentic AI and digital orchestration within regulated life sciences supply chains.
  • TraceLink's OPUS platform has undergone transformation to embed governed AI into operational workflows, reducing deployment timelines from months to weeks.
  • TraceLink has launched its first production AI Assistants and Agents for exception management, procure-to-pay, and other processes.

The big picture

TraceLink's recognition underscores the growing adoption of AI-driven orchestration in the life sciences sector, driven by the need for greater supply chain resilience and agility. The company's focus on governed AI and a no-code architecture positions it to capitalize on this trend, but also introduces complexities related to scalability and regulatory oversight. This move reflects a broader industry shift towards leveraging digital networks and AI to automate processes and improve visibility within complex, global supply chains.

What we're watching

Governance Dynamics
The success of TraceLink's AI strategy hinges on maintaining regulatory compliance and auditability, a critical factor given the highly regulated nature of the life sciences industry.
Execution Risk
Scaling agentic AI across a network of 291,000 entities presents significant operational challenges and requires robust infrastructure and process standardization.
Competitive Landscape
The emergence of agentic AI in life sciences supply chains will likely intensify competition, requiring TraceLink to continually innovate and differentiate its OPUS platform.

TraceLink Scales Agentic Orchestration After DSCSA Milestone

Event summary

  • TraceLink successfully executed the U.S. Drug Supply Chain Security Act (DSCSA) dispenser requirement, activating approximately 300 new DSCSA live links per week during peak periods.
  • The company's network now supports over 7 billion regulated transactions annually and has 310,000+ trading partners and 339,000+ active links.
  • TraceLink experienced 971% year-over-year growth in MINT live links and launched 21 new transaction workflows in 2025.
  • MINT customer base grew 59% year-over-year, with 584% growth in MINT link onboarding.

The big picture

TraceLink's success in navigating the DSCSA milestone and expanding its network demonstrates the growing need for specialized, regulated digital infrastructure within the life sciences industry. The shift from compliance-focused services to broader, agentic orchestration capabilities reflects a broader trend towards AI-driven automation and data-sharing across complex supply chains, potentially disrupting traditional ERP and WMS vendors. TraceLink's scale – linking hundreds of thousands of entities – creates a significant network effect, but also introduces operational complexity.

What we're watching

Execution Risk
The ability to translate the expanded network and standardized processes into tangible operational improvements for customers will be critical to TraceLink’s continued growth.
Agentic Adoption
The pace at which customers adopt and integrate TraceLink’s agentic orchestration capabilities will determine the platform’s long-term differentiation and value proposition.
Competitive Landscape
How TraceLink’s ‘network-is-the-product’ model fares against emerging, more modular supply chain solutions will shape its market position.

TraceLink Secures Third Consecutive Pharmacy500 Nod Amid Supply Chain Complexity

Event summary

  • TraceLink has been recognized for the third consecutive year on RXinsider's Pharmacy500 list.
  • The company's 'Business-to-Network Integrate-Once™' platform facilitates digitalization and compliance across the pharmacy supply chain.
  • TraceLink's network connects CMOs, brand manufacturers, wholesalers, logistics providers, health systems, and retail pharmacies.
  • The platform has processed over 9 billion EPCIS transactions and manages 73 billion commissioned serial numbers.
  • TraceLink boasts a 99.98%+ platform availability and a Platinum CyberVadis rating.

The big picture

TraceLink's recognition underscores the growing importance of digital supply chain orchestration in the pharmacy sector, driven by stricter regulatory requirements (DSCSA) and persistent operational challenges. The company's 'Integrate-Once™' model aims to reduce complexity and improve efficiency for pharmacies, which are increasingly reliant on technology to manage costs and maintain patient safety. The scale of TraceLink’s network – connecting over 291,000 entities – positions it as a key player in the evolving pharmacy supply chain landscape.

What we're watching

AI Integration
TraceLink's stated focus on integrating digital AI agents alongside pharmacy teams warrants monitoring; the success of this integration will depend on balancing automation with human oversight and regulatory approval.
Scalability
Maintaining 99.98%+ availability while processing billions of transactions and supporting hundreds of thousands of partners will require continued investment in infrastructure and robust operational processes.
Competitive Landscape
The Pharmacy500 recognition highlights TraceLink's position, but the ongoing pressure from rising drug costs and shortages will likely spur increased competition among supply chain orchestration providers.
CID: 1259